Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithymocyte Globulin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01081405
What this trial is testing

Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
HEMATOLOGIC MALIGNANCIES
Fondazione EMN Italy Onlus 20
Post-approval studies (Phase 4)Study completedNCT01729494
What this trial is testing

Belatacept Early Steroid Withdrawal Trial

Who this might be right for
Renal Transplantation
University of Cincinnati 316
Testing effectiveness (Phase 2)UnknownNCT03395860
What this trial is testing

Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT

Who this might be right for
Graft-versus-host-diseaseProphylaxis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT00475020
What this trial is testing

Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome

Who this might be right for
Myelofibrosis
M.D. Anderson Cancer Center 63
Early research (Phase 1)Study completedNCT00317798
What this trial is testing

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganMultiple Myeloma and Plasma Cell Neoplasm
University of Rochester 18
Testing effectiveness (Phase 2)Ended earlyNCT00542828
What this trial is testing

Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome (MDS)
Genzyme, a Sanofi Company 16
Not applicableEnded earlyNCT00235781
What this trial is testing

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

Who this might be right for
Kidney Transplantation
Washington University School of Medicine 90
Early research (Phase 1)Ended earlyNCT00354419
What this trial is testing

Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant

Who this might be right for
Aplastic Anemia
Fred Hutchinson Cancer Center 30
Post-approval studies (Phase 4)UnknownNCT03689465
What this trial is testing

PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 260
Large-scale testing (Phase 3)UnknownNCT01844635
What this trial is testing

Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA

Who this might be right for
Acquired Aplastic Anemia.
Nagoya University 320
Testing effectiveness (Phase 2)Study completedNCT03025698
What this trial is testing

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

Who this might be right for
Aplastic Anemia
Novartis Pharmaceuticals 51
Post-approval studies (Phase 4)UnknownNCT04203108
What this trial is testing

ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 266
Testing effectiveness (Phase 2)Active Not RecruitingNCT04872595
What this trial is testing

A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Lymphoid Leukemia (ALL)Myelodysplastic Syndromes (MDS)
Memorial Sloan Kettering Cancer Center 59
Post-approval studies (Phase 4)UnknownNCT03789006
What this trial is testing

Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
University of Khartoum 300
Early research (Phase 1)Study completedNCT00697684
What this trial is testing

Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphocytic Leukemia+4 more
Beth Israel Deaconess Medical Center 29
Early research (Phase 1)UnknownNCT00436761
What this trial is testing

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT02876679
What this trial is testing

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

Who this might be right for
Graft vs Host Disease
Assistance Publique - Hôpitaux de Paris 94
Large-scale testing (Phase 3)Study completedNCT00105183
What this trial is testing

EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

Who this might be right for
Chronic Obstructive PulmonaryIdiopathic Pulmonary FibrosisCystic Fibrosis+2 more
Neovii Biotech 223
Early research (Phase 1)Study completedNCT00301951
What this trial is testing

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of California, San Francisco 7
Testing effectiveness (Phase 2)Study completedNCT00378768
What this trial is testing

Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center 12
Next Page